This is the current release of the guideline.

The relationship between the strength of evidence of effectiveness and the strength of the recommendation is defined at the end of the "Major Recommendations" field.

On the basis of strong evidence of effectiveness, the Task Force recommends early childhood home visitation for prevention of child abuse and neglect in families at risk for maltreatment, including disadvantaged populations and families with low-birthweight infants.

Evidence was insufficient to determine the effectiveness of early childhood home visitation in preventing violence by visited children. The studies also yielded insufficient evidence to determine the effectiveness of early childhood home visitation in preventing violence by visited parents (other than child abuse and neglect) or intimate partner violence in visited families.

Definitions:

Strength of Evidence of Effectiveness = Strength of Recommendation

The strength of each recommendation is based on the evidence of effectiveness (i.e., an intervention is recommended on the basis of either strong or sufficient evidence of effectiveness).

If insufficient evidence to determine effectiveness is found, this means that it was not possible to determine whether or not the intervention works based on the available evidence.

None provided

The recommendations are based on qualifying studies, all of which had good or fair execution quality. In general, the strength of evidence of effectiveness corresponds directly to the strength of recommendations (see the "Major Recommendations" field).

Not applicable: The guideline was not adapted from another source.

2003 Oct 3

Task Force on Community Preventive Services - Independent Expert Panel

U.S. Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)

Task Force on Community Preventive Services

Task Force: Chair: Jonathan E. Fielding, M.D., M.P.H., M.B.A.), Los Angeles Department of Health Services, Los Angeles, California Vice-Chair: Patricia Dolan Mullen, Dr.P.H., University of Texas-Houston School of Public Health, Houston, Texas

Members: Ross C. Brownson, Ph.D., St. Louis University School of Public Health, St. Louis, Missouri; John Clymer, Partnership for Prevention, Washington, D.C.; Jane L. Delgado, Ph.D., M.S., National Alliance for Hispanic Health, Washington, D.C.; Mindy Thompson Fullilove, M.D., New York State Psychiatric Institute and Columbia University, New York, New York; Alan R. Hinman, M.D., M.P.H., Task Force for Child Survival and Development, Atlanta, Georgia; George J. Isham, M.D., HealthPartners, Minneapolis, Minnesota; Garland H. Land, M.P.H., Center for Health Information Management and Epidemiology, Missouri Department of Health, Jefferson City, Missouri; Patricia A. Nolan, M.D., M.P.H., Rhode Island Department of Health, Providence, Rhode Island; Dennis E. Richling, M.D., Union Pacific Railroad, Omaha, Nebraska; Susan C. Scrimshaw, Ph.D., School of Public Health, University of Illinois, Chicago, Illinois; Steven M. Teutsch, M.D., M.P.H., Merck & Company, Inc., West Point, Pennsylvania; Robert S. Thompson, M.D., Department of Preventive Care, Group Health Cooperative of Puget Sound, Seattle, Washington

Consultants: Robert S. Lawrence, M.D., Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; J. Michael McGinnis, M.D., Robert Wood Johnson Foundation, Princeton, New Jersey; Lloyd F. Novick, M.D., M.P.H., Onondaga County Department of Health, Syracuse, New York

Research conducted by: Robert A. Hahn, PhD, Division of Prevention Research and Analytic Methods, Epidemiology Program Office; Oleg O. Bilukha, MD, PhD, Division of Prevention Research and Analytic Methods, Epidemiology Program Office; Alex Crosby, MD, Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia; Mindy T. Fullilove, MD, New York State Psychiatric Institute, Columbia University, New York, New York; Akiva Liberman, PhD, National Institute of Justice, U.S. Department of Justice, Washington, DC; Eve K. Moscicki, ScD, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland; Susan Snyder, PhD, Division of Prevention Research and Analytic Methods, Epidemiology Program Office; Farris Tuma, ScD, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland; Amanda Schofield, MPH, Division of Prevention Research and Analytic Methods, Epidemiology Program Office; Phaedra S. Corso, PhD, Division of Prevention Research and Analytic Methods, Epidemiology Program Office; Peter Briss, MD, Division of Prevention Research and Analytic Methods, Epidemiology Program Office

Not stated

This is the current release of the guideline.

None available

This NGC summary was completed by ECRI on May 28, 2004. The information was verified by the guideline developer on July 9, 2004.

No copyright restrictions apply.